Cox-2 selective carprofen for treating pain and inflammation in dogs
CA 2288759 A1 · Owner: Lundy, Kristin Marie · Inventors: Ricketts, Anthony Paul; Lundy, Kristin Marie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Treating or preventing inflammatory processes and diseases in dogs associated with the activity of inducible cyclo-oxygenase-2 (COX-2) while at the same , time reducing or eliminating undesirable side effects associated with simultaneous inhibition of the activity of constitutive cyclo-oxygenase-1 (COX- 1) by selectively inhibiting COX-2 activity with reference to COX-1 activity wherein the selectivity ratio or COX-2 : COX-1 activity inhibition is at least 3 : 1 based on ex vivo inhibition levels measured in whole blood; the inhibitor is a member selected from the group of anti-inflammatory compounds consisting essentially of salicylic acid derivatives p-aminophenol , derivatives, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 1, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 1, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 1, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.